{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:55:57Z","timestamp":1780048557907,"version":"3.53.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ejphar.2006.02.016","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T12:41:16Z","timestamp":1142426476000},"page":"208-211","source":"Crossref","is-referenced-by-count":11,"title":["Chronic valproate fails to prevent imipramine-induced behavioural sensitization to the dopamine D2-like receptor agonist quinpirole"],"prefix":"10.1016","volume":"535","author":[{"given":"Paolo S.","family":"D'Aquila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Panin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.02.016_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0165-0327(98)00161-X","article-title":"Current research on rapid-cycling bipolar disorder and its treatment","volume":"67","author":"Calabrese","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2006.02.016_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(00)00189-8","article-title":"Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D2-like receptor agonist quinpirole","volume":"395","author":"D'Aquila","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/026988110001400419","article-title":"Different effect of desipramine on locomotor activity in quinpirole-treated rats after repeated restraint and chronic mild stress","volume":"14","author":"D'Aquila","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(01)00876-7","article-title":"Carbamazepine prevents imipramine-induced behavioural sensitization to the D2-like dopamine receptor agonist quinpirole","volume":"416","author":"D'Aquila","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib6","series-title":"3rd International Forum on Mood and Anxiety Disorders, November 27\u201330 2002, Monte-Carlo","first-page":"244","article-title":"Role of BDNF in the ventral tegmental area in the development of dopaminergic behavioural supersensitivity induced by chronic imipramine","volume":"vol. 6","author":"D'Aquila","year":"2003"},{"key":"10.1016\/j.ejphar.2006.02.016_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.fbp.0000190682.92607.0c","article-title":"Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity","volume":"17","author":"D'Aquila","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0924-977X(95)00023-I","article-title":"Sleep deprivation in the rat: an animal model of mania","volume":"5","author":"Gessa","year":"1995","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1399-5618.2003.00074.x","article-title":"Antidepressant in bipolar disorder: the case for caution","volume":"5","author":"Ghaemi","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejphar.2006.02.016_bib10","series-title":"Psychopharmacology: The Third Generation of Progress","first-page":"505","article-title":"Role of dopamine mechanism in affective disorders","author":"Jimerson","year":"1987"},{"key":"10.1016\/j.ejphar.2006.02.016_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004850-198804000-00003","article-title":"Carbamazepine in rapid cycling bipolar affective disorder","volume":"3","author":"Joyce","year":"1988","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib12","series-title":"Depression and Mania: From Neurobiology to Treatment","first-page":"127","article-title":"The long term prophylaxis of affective disorders","volume":"vol. 49","author":"Koukopoulos","year":"1995"},{"key":"10.1016\/j.ejphar.2006.02.016_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00004714-199110000-00007","article-title":"Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients","volume":"11","author":"Leinonen","year":"1991","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib14","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"461","article-title":"Drugs effective in the therapy of epilepsies","author":"McNamara","year":"1996"},{"key":"10.1016\/j.ejphar.2006.02.016_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000118969","article-title":"Effects of carbamazepine and lithium on affective disorders","volume":"27","author":"Okuma","year":"1993","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejphar.2006.02.016_bib17","first-page":"62","article-title":"Prophylactic efficacy of carbamazepine in manic-depressive illness","volume":"48","author":"Post","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2006.02.016_bib16","first-page":"421","article-title":"The efficacy of carbamazepine in affective illness","volume":"39","author":"Post","year":"1984","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-1781(87)90064-3","article-title":"Correlates of antimanic response to carbamazepine","volume":"21","author":"Post","year":"1987","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2006.02.016_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0006-8993(90)91142-4","article-title":"Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants","volume":"527","author":"Serra","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.02.016_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004850-200015040-00001","article-title":"Recent advances in the treatment of bipolar mania, depression. Mixed states, and rapid cycling","volume":"15","author":"Soares","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2006.02.016_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0447.2003.00126.x","article-title":"Rapid-cycling bipolar disorder: effects of long-term treatments","volume":"108","author":"Tondo","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2006.02.016_bib22","series-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1971"},{"key":"10.1016\/j.ejphar.2006.02.016_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-8993(00)02996-6","article-title":"Valproate modulates the expression to methylphenidate (ritalin) sensitisation in rats","volume":"887","author":"Yang","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.02.016_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(02)03141-4","article-title":"Valproate prevents the induction and the expression of MK-801 sensitisation","volume":"954","author":"Yang","year":"2002","journal-title":"Brain Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T20:50:52Z","timestamp":1547758252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299906001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":24,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0014299906001609"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.02.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}